AEHRAehr Test Systems, Inc.

$84.67+183% 1Y

Is the business good?

Watch

More warning than reassurance: 2 of 9 health tests passed and margins compressing.

2 to watch, 2 without data
Fundamental health (F-score)2 / 9SEC EDGAR · May 29, 2026

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−51.7 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is AEHR?

Aehr Test Systems, Inc. earns −11% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−11%

Return on invested capital · cost of capital 9.0% · 20 points below what the capital costs: growth destroys value

Operating margin
−28%

Operating margin · Semiconductor Equipment & Materials median 11% · 12 months to Q4 2026

R&D as % of revenue
25%

R&D as % of revenue

Gross margin
35%

Gross margin

Operating margin by fiscal year
YearOperating margin
FY2021−25%
FY202215%
FY202321%
FY202415%
FY2025−9.6%
FY2026−28%
Details›
Gross margin12 months to Q4 2026
35%
Operating margin12 months to Q4 2026
−28%
Net margin12 months to Q4 2026
−14%
Free cash flow margin
−11%
R&D as % of revenue
25%
Revenue, trailing twelve months
$50M
Free cash flow, trailing twelve months
−$5.4M
Net income, trailing twelve months
−$7.1M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−11%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

On our screens:Most shorted stocks